Cite
HARVARD Citation
Langley, J. et al. (2015). Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial. Vaccine. 33 (4), pp. 559-567. [Online].